Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI

Go back to Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI
(NASDAQ: CMND) Delayed: 0.99 -0.17 (14.66%)
Previous Close $1.16    52 Week High
Open $1.15    52 Week Low
Day High $1.15    P/E N/A 
Day Low $0.92    EPS
Volume 1,917,560